Incidence and Risk of Thyroid Dysfunction in Advanced or Metastatic Non-small Cell Lung Cancer Patients Treated with Pembrolizumab: A Meta-analysis

Thyroid dysfunction is one of the major side effects associated with Pembrolizumab in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC). We performed a systematic review and meta-analysis of randomized clinical trials to determine its overall incidence. A literature search w...

Descripción completa

Detalles Bibliográficos
Autores principales: Abid, Haisam, Khavandi, Maryam, Siddiqui, Nadir, Panjawatanan, Panadeekarn, Patel, Anush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Pulmonology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876924/
https://www.ncbi.nlm.nih.gov/pubmed/31807385
http://dx.doi.org/10.7759/cureus.5997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876924/
https://www.ncbi.nlm.nih.gov/pubmed/31807385
http://dx.doi.org/10.7759/cureus.5997

Ejemplares similares